Federal action to lower the cost of drugs
The pharmaceutical industry in the United States produces more groundbreaking medical treatments than it does in any other nation. Particularly noteworthy are advances in the treatment of previously incurable cancers and debilitating genetic disorders. Yet these laudable successes increasingly have been overshadowed by a growing crisis in the affordability of prescription-brand drugs, particularly the cutting-edge … Read more